FDA Recalls Compounded Folic Acid Injectable Solution Due to Sterility Concerns
Moses Lake Professional Pharmacy is recalling compounded folic acid injectable solution because the agency cannot assure the product is sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating (Score 4) under the rubric, particularly given the risk of infection associated with non-sterile injectable drugs.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for compounded folic acid injectable solution manufactured by JD & SN Inc., dba Moses Lake Professional Pharmacy. The product is a prescription-only, 5 mg/mL solution packaged in 5 mL syringes. The recall involves 3 syringes with the code t06032015@23.
The recall was initiated due to a lack of assurance of sterility. The FDA notes that all sterile human compounded drugs within their expiry date are affected by this concern. The distribution pattern for this product is listed as nationwide.
Consumers and healthcare providers should stop using the affected folic acid injectable solution and contact their pharmacist or the recalling firm, Moses Lake Professional Pharmacy, for further instructions on how to return or dispose of the product.
The recalled product
- Product
- FOLIC ACID (COMPOUNDED), Injectable Solution, 5 mg/mL, 5 mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Injectable
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t06032015@23
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereRXQ Compounding Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereFolic Acid Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereFolic Acid 10mg/mL Injectable Recalled Due to Sterility Concerns
FDA (Drugs) · 2021-11-03
- SeverePromise Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereKey Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereWestern Drug Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09